Search company, investor...

Founded Year

2010

Stage

Loan | Alive

Total Raised

$62.59M

Last Raised

$1.5M | 4 yrs ago

About Ionetix Corporation

Ionetix Corporation is a molecular imaging diagnostics and therapeutics company in the healthcare sector. The company provides cutting-edge diagnostic and therapeutic radiopharmaceuticals, with a focus on cardiac PET imaging using N-13 Ammonia. Its primary customers are health systems, hospitals, and practice groups in cardiology and radiology/nuclear medicine. Ionetix Corporation was formerly known as Aion Cyclotrons, Inc.. It was founded in 2010 and is based in San Francisco, California.

Headquarters Location

101 The Embarcadero Suite 210

San Francisco, California, 94105,

United States

415-944-1440

Loading...

Loading...

Ionetix Corporation Patents

Ionetix Corporation has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/7/2011

10/15/2013

Mass spectrometry, Accelerator physics, Particle physics facilities, Ion source, Superconductivity

Grant

Application Date

7/7/2011

Grant Date

10/15/2013

Title

Related Topics

Mass spectrometry, Accelerator physics, Particle physics facilities, Ion source, Superconductivity

Status

Grant

Latest Ionetix Corporation News

Ionetix to provide Bayer with Therapeutic Radioisotope Actinium-225 (Ac-225)

Nov 15, 2023

News provided by Share this article Share toX LANSING, Mich., Nov. 15, 2023 /PRNewswire/ -- Ionetix Corporation today announced the signing of a supply agreement for the therapeutic radioisotope actinium-225 (Ac-225) with Bayer. Under the terms of the agreement, Ionetix will provide Bayer with high-purity, non-carrier added (n.c.a.) Ac-225. Ac-225 is an alpha-emitter and when attached to a tumor seeking molecule, can deliver therapeutic doses of radiation directly to tumors, destroying the cancer cells while sparing the surrounding healthy tissue. Precision targeting of cancer using targeted radionuclide therapies (TRT) is a promising new cancer treatment approach. However, the global availability of Ac-225 is limited and currently there are very few production resources. Therefore, there is an immediate need for new sources of Ac-225 supply that can scale effectively to support the development of these new cancer treatments. "We recognized the emerging demand and made the early investment to develop a commercial-scale production solution for Ac-225 using our expertise in cyclotron accelerator and target technology," said David Eve, VP of Medical Affairs for Ionetix Corporation. Located in Lansing, Michigan, Ionetix has established a new isotope production facility that is dedicated to manufacturing alpha-emitters. The first cyclotron was commissioned at the facility earlier this year and installation of a second cyclotron is planned for 2024. Both cyclotrons will be used to produce alpha-emitters, providing both onsite redundancy and increased capacity to scale output. Distribution of GMP grade, n.c.a. Ac-225 will begin in early 2024. About IONETIX Utilizing a proprietary cyclotron technology platform, Ionetix is focused on developing innovative solutions for the production and distribution of radioisotopes used for diagnostic and therapeutic radiopharmaceuticals. Ionetix offers turnkey services for the point-of-care supply of diagnostic positron emission tomography (PET) radiopharmaceuticals N-13 Ammonia and Ga-68. Ionetix is now expanding its services to include the supply of alpha-emitting radioisotopes used in therapeutic radiopharmaceuticals being developed to treat various cancers. Ionetix recently established the first dedicated alpha isotope manufacturing and distribution facility to produce alpha isotopes Actinium-225 and Astatine-211 in Lansing, Michigan. https://www.ionetix.com/ SOURCE IONETIX

Ionetix Corporation Frequently Asked Questions (FAQ)

  • When was Ionetix Corporation founded?

    Ionetix Corporation was founded in 2010.

  • Where is Ionetix Corporation's headquarters?

    Ionetix Corporation's headquarters is located at 101 The Embarcadero, San Francisco.

  • What is Ionetix Corporation's latest funding round?

    Ionetix Corporation's latest funding round is Loan.

  • How much did Ionetix Corporation raise?

    Ionetix Corporation raised a total of $62.59M.

  • Who are the investors of Ionetix Corporation?

    Investors of Ionetix Corporation include Paycheck Protection Program.

  • Who are Ionetix Corporation's competitors?

    Competitors of Ionetix Corporation include Lawrenceville Plasma Physics and 4 more.

Loading...

Compare Ionetix Corporation to Competitors

P
Particle Accelerator Corporation

Particle Accelerator Corporation is a Downers Grove, IL based company that has received a grant(s) from the Department of Energy's SBIR/STTR program. The abstract(s) for these grant award(s) are provided as well since they provide insights into Particle Accelerator Corporation's business and areas of expertise. This project will develop a viable proton and light-ion accelerator for both research and commercial use while eliminating some of the most pronounced technical difficulties, expense, maintenance, and required expertise faced in conventional accelerators. Proton and light-ion accelerators have many research and medical applications, providing one of the most effective treatments for many types of cancer. The development of broad, highly-accurate accelerator models with powerful optimization tools and user-friendly interfaces will enhance not only the HEP program but also benefit established and future applications of accelerators in science, technology, and medicine ranging from treatment of cancers, radiopharmaceuticals, and medical isotope production to secondary production beams for material science and basic research in nuclear physics.

O
Omega-P

Omega-P, Inc. is a New Haven, CT based company that has received a grant(s) from the Department of Energy's SBIR/STTR program. The abstract(s) for these grant award(s) are provided as well since they provide insights into Omega-P, Inc.'s business and areas of expertise. This project will develop a rapidly-adjustable, cathode to improve proton beam quality used with an electron lens. This cathode will have applications for vacuum tubes employed for telecommunications and radar, in both civilian and military systems. This project will develop high-power microwave switches to allow tests of structures to sustain higher electric fields without breakdown, thus enabling operation at higher energy, and also opening up commercial applications with improved clinical accelerators. Intense proton beams can be used for disposal of waste from nuclear reactor spent fuel rods, and other applications. This project is to explore a new concept for a compact accelerator to generate the proton beam. Basic laboratory studies are needed to understand high field limits in candidate structures for a future affordable particle accelerator. This project aims to build a new microwave source for this purpose with minimum investment in new technology. This project will develop high-power multi-beam klystrons that should lower cost and complexity for a future electron-positron collider, and also open up commercial applications with improved clinical accelerators and industrial processors. Progress in elementary particle high-energy physics depends on the evolution of technology to enable future machines to operate at higher energies than can be reached at present. The high-power multi-beam klystrons to be developed should lower cost and complexity for a future electron-positron collider. Progress in elementary particle high-energy physics depends on the evolution of technology to enable future machines to operate at higher energies than can be reached at present. This project will develop high-gradient cavities to allow structures to sustain higher electric fields without breakdown, thus enabling operation at higher energy, and also opening up commercial applications with improved clinical accelerators. Progress in elementary particle high-energy physics depends on the evolution of technology to enable future machines to operate at higher energies than can be reached at present. The high-gradient cavities to be developed in this project are to allow structures to sustain higher electric fields without breakdown, thus enabling operation at higher energy, and also opening up commercial applications with improved clinical accelerators. This project will develop high-gradient cavities to allow structures to sustain higher electric fields without breakdown, thus enabling operation at higher energy, and also opening up commercial applications with improved clinical accelerators. Progress in nuclear physics and elementary particle high-energy physics depends on the evolution of technology to enable future machines to operate at higher particle fluxes and higher energies than can be reached at present. The fast ferroelectric tuners to be developed in this project are to allow accelerator cavities to sustain high accelerating fields despite uncontrolled mechanical vibrations that would otherwise detune the cavities and degrade the accelerator performance. To maintain a leading role in physics for U.S. scientists and laboratories, basic research on fundamental origins of mass are needed. The proposed project is to develop a fast tuner to maintain needed synchronism in the planned accelerator upgrade to increase the brightness of the heavy ion beam in RHIC. Intense proton beams can be used for disposal of waste from nuclear reactor spent fuel rods, and other applications. This project is to explore a new concept for a compact accelerator to generate the proton beam. To maintain a leading role in high-energy physics for U.S. scientists and laboratories, basic research on means of building powerful particle accelerators is needed. The proposed project is to develop a high-power microwave source needed for fundamental studies to understand how to achieve strong acceleration, and thus make possible future design of a multi-teravolt electron-positron collider.

Niowave Logo
Niowave

Niowave is a company focused on the production of medical and industrial radioisotopes, operating within the medical and industrial sectors. The company's main offerings include the manufacturing of radioisotopes from uranium and radium, which are used in the treatment of cancer and other medical applications. These radioisotopes are primarily sold to the medical industry. It was founded in 2005 and is based in Lansing, Michigan.

M
Muons

Muons, Inc. is a Batavia, IL based company that has received a grant(s) from the Department of Energy's SBIR/STTR program. The abstract(s) for these grant award(s) are provided as well since they provide insights into Muons, Inc.'s business and areas of expertise. This project will develop process to accelerate muons in hydrogen-filled RF cavities to create small, intense beams to enhance their utility for many applications ranging from homeland security to energy frontier muon colliders. This project will provide optical fiber-based sensors to monitor and protect the superconducting magnets used for fusion reactors, particle accelerators, and magnetic resonance imaging. This project will develop a technique to use high-pressure gas to study the breakdown mechanisms of RF cavities needed for particle accelerators. A successful outcome would provide cost reductions and performance improvements for many accelerator projects, including the International Linear Collider. This project will develop an acceleration technique for future Neutrino Factories and Muon Colliders to take advantage of the high gradient RF cavities that are being developed for the International Linear Collider. This project will develop unrecognized material choices for RF windows which help feed power into superconducting accelerating structures. These material options will increase the window power handling capabilities and mechanical strength over existing designs. This project will develop a new system of superconducting magnets to shrink the size of a beam of muons in all dimensions to investigate nature at fundamental levels at the energy frontier and for several other scientific and commercial applications. New beam cooling techniques will be applied to create an intense beam of low-energy muons that will stop in a small volume for particle physics experiments of exquisite sensitivity, muon spin resonance studies, and muon-catalyzed fusion. Ceramics with specific changes in resistivity throughout their volume will be developed and manufactured to improve very high voltage gradients in DC guns used for accelerator research and industrial applications. A device to produce H- ions, which are each made up of a proton and two electrons, is being developed to enable higher intensity beams with better reliability and improved efficiency for many powerful particle accelerators used in science, industry, and homeland defense. Co-axial window technology is being improved with new materials and techniques in order to transfer RF power from sources to RF cavities at very high levels to satisfy the demands of intense light sources used for science and industry. Superconducting RF cavity systems will be improved by developing better designs and materials for the absorption of unwanted higher order mode (HOM) frequencies that lead to beam instabilities in synchrotron light sources. High-temperature superconducting wire is being developed to operate at low temperature for extremely high field magnets for particle accelerators and Nuclear Magnetic Resonance. Beams of muons would have many commercial and scientific uses if the disadvantage of their short lifetime can be overcome. New ways to collect large numbers of muons and to form them rapidly into bright beams are being developed for many applications, including a muon collider at the energy frontier. Highly efficient and inexpensive magnetrons, such as those used in kitchen microwave ovens, are being developed to provide the lowest cost microwave sources for a number of diverse applications, including particle accelerators, phased array radars, and sputtering systems. A new system of superconducting magnets is being developed to shrink the size of a beam of muons in all dimensions. The bright muon beams that will emerge from these magnets will enable new ways to investigate nature at fundamental levels at the energy frontier. New beam cooling techniques are being applied to create an intense beam of low-energy muons that will stop in a small volume in order to do particle physics experiments of exquisite sensitivity. Such stopping beams will also aid the development of applications such as muon spin resonance and muon-catalyzed fusion. Innovative accelerating structures are being developed for fixed-field alternating gradient synchrotrons to provide high intensity beams of ions, protons, muons, and electrons for basic research and for cancer therapy.

D
DULY Research

DULY Research Inc. is a Rancho Palos Verdes, CA based company that has received a grant(s) from the Department of Energy's SBIR/STTR program. The abstract(s) for these grant award(s) are provided as well since they provide insights into DULY Research Inc.'s business and areas of expertise. This project will develop a polarized electron source that provides a high quality beam at a much reduced cost. The source developed will benefit both the nuclear physics community and International Linear Collider (ILC). This project will develop a voltage droop compensation scheme that will provide a simple, reliable, and cost effective method to allow a high voltage Marx modulator produce a flattop voltage pulse as specified in the ILC project. Other accelerator facilities which need long pulse modulators will also benefit from the results of this project. Filling a gap in the electromagnetic spectrum that lies between the microwave/millimeter wave and the infrared regions, this project will develop a new, compact terahertz source based on a photoelectron linear accelerator to meet the high demand in broad applications for biology, superconductivity, chemistry, physics, environmental monitoring, satellite communications and homeland security. This project will develop a fluid controlled, tunable RF coupler for both normal conducting and superconducting RF cavities. This is an important innovation in the fields of RF accelerators and power sources. This project aims at the development of a new, compact, Terahertz radiation source for myriad applications. The commercial goal is to deliver an effective tool for smaller labs and businesses in biology, solid-state physics, superconductivity, environment monitoring, homeland security, defense, communication, and medicine.

Vital Energi Logo
Vital Energi

Vital Energi is a company that focuses on low carbon energy generation, distribution, and management in the energy sector. The company offers a range of services including the development of heat networks, the installation of heat pumps, solar energy solutions, and battery storage systems. They primarily cater to sectors such as further education, healthcare, residential (both new build and retrofit), commercial and industrial, urban networks, and power generation. It is based in Blackburn, United Kingdom.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.